Vanguard Group Inc. lifted its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 21.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,300,725 shares of the company’s stock after purchasing an additional 225,474 shares during the quarter. Vanguard Group Inc. owned 6.41% of PetMed Express worth $52,810,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Acrospire Investment Management LLC purchased a new position in shares of PetMed Express in the second quarter worth $110,000. Pinebridge Investments L.P. raised its stake in shares of PetMed Express by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after purchasing an additional 27 shares during the last quarter. State of Alaska Department of Revenue raised its stake in shares of PetMed Express by 76.7% in the second quarter. State of Alaska Department of Revenue now owns 4,028 shares of the company’s stock worth $163,000 after purchasing an additional 1,748 shares during the last quarter. Arizona State Retirement System raised its stake in shares of PetMed Express by 0.9% in the first quarter. Arizona State Retirement System now owns 10,667 shares of the company’s stock worth $215,000 after purchasing an additional 100 shares during the last quarter. Finally, Weatherly Asset Management L. P. purchased a new position in shares of PetMed Express in the second quarter worth $216,000. Hedge funds and other institutional investors own 81.08% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.watchlistnews.com/petmed-express-inc-pets-stake-lifted-by-vanguard-group-inc/1677483.html.

In other PetMed Express news, Director Ronald J. Korn sold 1,000 shares of the company’s stock in a transaction on Friday, October 27th. The stock was sold at an average price of $35.57, for a total value of $35,570.00. Following the completion of the transaction, the director now owns 73,833 shares in the company, valued at approximately $2,626,239.81. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.00% of the stock is owned by corporate insiders.

Shares of PetMed Express, Inc. (NASDAQ:PETS) opened at $36.56 on Friday. The firm has a market capitalization of $769.57 million, a P/E ratio of 25.07, a price-to-earnings-growth ratio of 2.25 and a beta of 1.09.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. The firm had revenue of $66.70 million during the quarter, compared to the consensus estimate of $63.41 million. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.24 EPS. research analysts anticipate that PetMed Express, Inc. will post 1.66 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 17th. Shareholders of record on Monday, November 6th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $0.80 dividend on an annualized basis and a yield of 2.19%. PetMed Express’s dividend payout ratio (DPR) is presently 53.69%.

Several research analysts have recently weighed in on the company. Noble Financial restated a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. Zacks Investment Research upgraded PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 price target for the company in a research note on Friday, October 20th. ValuEngine cut PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Credit Suisse Group restated an “underperform” rating and issued a $19.00 price target on shares of PetMed Express in a research note on Monday, October 2nd. Finally, Sidoti upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price target for the company in a research note on Thursday, August 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. PetMed Express currently has a consensus rating of “Hold” and an average price target of $42.00.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.